Sandoz Looks To Biosimilars As It Reprioritizes In The US

US Sandoz President Carol Lynch Talks Changing Portfolio

Carol Lynch, Sandoz US
Sandoz US President Carol Lynch • Source: Sandoz
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business